ImmunityBio, Inc 10-K for FY2021
ImmunityBio, Inc. (IBRX)
10-K
2022-03-01
For: 2021-12-31
View Original
Added on
April 10, 2026
About this 10-K
ImmunityBio, Inc filed this 10-K on March 1, 2022, covering the fiscal year ended December 31, 2021 (FY2021).
Headline figures
Fiscal year ended December 31, 2021, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $934K
- up 54.4% from $605K a year earlier
- Net loss
- $346.79M
- compared with a net loss of $221.85M a year earlier
- Diluted EPS
- -$0.89
- compared with -$0.59 a year earlier